OOIR: Observatory of International Research

Papers

(The H4-Index of BMJ Open Respiratory Research is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Differences in risk indicators associated with electronic cigarette use and tobacco smoking among adolescents and young people in Nigeria	99
Differences in uni-dimensional breathlessness measures and thresholds for clinical response in a randomised controlled trial in people with chronic breathlessness: an exploratory study	67
Comparing the impact of targeting limited driving pressure to low tidal volume ventilation on mortality in mechanically ventilated adults with COVID-19 ARDS: an exploratory target trial emulation	57
Bagasse dust exposure and chronic respiratory symptoms among workers in the Metehara and Wonji sugar factories in Ethiopia: a longitudinal study design	50
Chronic obstructive pulmonary disease is a risk factor for non-tuberculous mycobacterial pulmonary disease: a population-based matched cohort study	49
Protection conferred by SARS-CoV-2 infection across a spectrum of reinfection symptoms and severities	45
Effect of a home-based inspiratory muscle training programme on functional capacity in postdischarged patients with long COVID: the InsCOVID trial	44
Evaluation of the Norwegian version of the Dyspnoea-12 questionnaire in patients with COPD	43
Exploring the predictors and barriers to accepting smoking cessation support within a targeted lung health check setting	41
Association between birth weight and chronic obstructive pulmonary disease in the UK Biobank: a prospective cohort study	38
Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank)	34
IPDMA – RADICAL – NSCLC: individual participant data meta-analysis and systematic review of radical local therapy for oligometastatic NSCLC	33
Elucidating the risk of cardiopulmonary consequences of an exacerbation of COPD: results of the EXACOS-CV study in Germany	30
Withdrawal of inhaled corticosteroids from patients with COPD with mild or moderate airflow limitation in primary care: a feasibility randomised trial	28
Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases	27
Impact of early caffeine administration on respiratory outcomes in very preterm infants initially receiving invasive mechanical ventilation	26
Temperature synchronisation of circadian rhythms in primary human airway epithelial cells from children	25
Association of high-sensitivity CRP and FEV1%pred: a study on non-pulmonary disease in a population in Beijing, China	24
What if… your research is suddenly affiliated with a tobacco manufacturing company?	24
Lung Health Check pilot: Ireland’s flagship lung cancer screening trial	23
COPD and vitamin K antagonism: a cohort study of 1-year all-cause mortality and risk of hospitalisation due to a severe exacerbation	23
Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β₂-agonist dual therapy in a primary care setting in Eng	23
Hospital-level variation in practices and outcomes for patients with severe acute exacerbations of idiopathic pulmonary fibrosis: a retrospective multicentre cohort study	23
Inhibition of GALNT7 suppresses cell proliferation and invasiveness while elevating cell apoptosis via the inactivation of the AKT pathway in non-small cell lung cancer	23
Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration	23

Respiratory oscillometry: the new kid on the lung function block